VWF and Genetic thrombotic microangiopathy: Lastly, the release of IL-6 may at least in part account for the high levels of circulating VWF, but also in the decrease of ADAMTS13 activity, leading to a pro-aggregant phenotype and thrombotic microangiopathy-like features (10, 13).